Warfarin Sodium Clathrate [(C19H15NaO4)‧(C3H8O)1/2] contains not less than 98.0% and not more than 102.0% of Warfarin Sodium, calculated on the anhydrous and propan-2-ol free substance.

共有 1 個藥物證書使用此成份

申請商
新雙隆生技股份有限公司 
適應症
抗凝血劑
含量
發證日期
2014-12-29